This study tests an experimental drug called radiprodil in 30 people with tuberous sclerosis complex (TSC) or focal cortical dysplasia (FCD) type II whose seizures have not improved with at least two other medications. The main goals are to check the drug's safety and how the bod…
Phase: PHASE1, PHASE2 • Sponsor: GRIN Therapeutics, Inc. • Aim: Symptom relief
Last updated May 17, 2026 11:01 UTC